Introduction Executive Summary Platelet-derived growth factor receptor antagonists: Overview • Structure • Mechanism of Action Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Platelet-derived growth factor receptor antagonists – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Platelet-derived growth factor receptor antagonists companies’ collaborations, Licensing, Acquisition -Deal Value Trends Platelet-derived growth factor receptor antagonists Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis Lenvatinib: Eisai • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II/III) • Comparative Analysis Quizartinib: Daiichi Sankyo Company • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Drug name: Company name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Pre-clinical and Discovery Stage Products • Comparative Analysis AGN-151200: Molecular Partners AG • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Platelet-derived growth factor receptor antagonists Key Companies Platelet-derived growth factor receptor antagonists Key Products Platelet-derived growth factor receptor antagonists- Unmet Needs Platelet-derived growth factor receptor antagonists- Market Drivers and Barriers Platelet-derived growth factor receptor antagonists- Future Perspectives and Conclusion Platelet-derived growth factor receptor antagonists Analyst Views Platelet-derived growth factor receptor antagonists Key Companies Appendix

Table 1 Total Products for Platelet-derived growth factor receptor antagonists Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Eisai • Daiichi Sankyo Company • Jiangsu Hengrui Medicine • Boehringer Ingelheim • Betta Pharmaceuticals • Tyrogenex • Pfizer • Metagone Biotech • Bayer Healthcare • AROG Pharmaceuticals • Pfizer • Molecular Partners • Xspray Pharma